Curated News
By: NewsRamp Editorial Staff
June 26, 2025
Unite for HER & Gilead Launch Free Cancer Care Program for Underserved
TLDR
- Unite for HER and Gilead Sciences offer a competitive edge by providing free integrative care to underserved metastatic breast cancer patients, enhancing treatment adherence and quality of life.
- The Metastatic Breast Cancer Sustainer Program methodically delivers free integrative therapies and support, including acupuncture and nutrition, to improve patient outcomes and treatment persistence.
- This partnership humanistically addresses healthcare disparities, offering dignity and equity through free, comprehensive care to marginalized metastatic breast cancer patients, fostering a healthier, more inclusive society.
- Discover how Unite for HER and Gilead Sciences' innovative program transforms lives with free integrative therapies for metastatic breast cancer patients, a beacon of hope and support.
Impact - Why it Matters
This initiative is a beacon of hope for metastatic breast cancer patients from underserved communities, offering them access to essential integrative therapies without financial burden. It addresses critical disparities in healthcare access and quality, ensuring that marginalized groups receive the comprehensive support they need to navigate their treatment and improve their well-being. This partnership not only enhances the lives of thousands of patients but also sets a precedent for corporate responsibility in addressing healthcare inequities.
Summary
In a groundbreaking partnership, Unite for HER (UFH) and Gilead Sciences have launched the 'Metastatic Breast Cancer Sustainer Program,' a free integrative care initiative aimed at Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of no-cost services including acupuncture, counseling, nutrition support, and fitness memberships, designed to improve patients' quality of life during their cancer journey. Sue Weldon, Founder and CEO of UFH, emphasizes the program's role in providing dignity, equity, and whole-person care, while Carmen Villar of Gilead Sciences highlights their commitment to innovative solutions for the metastatic breast cancer community. Since its inception in October 2023, the program has already supported over 2,823 patients, with Gilead Sciences' funding focusing on expanding access for marginalized groups. For more details, visit www.uniteforher.org.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Unite for HER & Gilead Launch Free Cancer Care Program for Underserved
